Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|21|10|893-900

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.21, Iss.10, 2016-10, pp. : 893-900

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab in Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 277-282

Karger

Access to resources Recommend Favorite

Treatment of Resistant/Relapsing Chronic Lymphocytic Leukemia with a Combination Regimen Containing Deoxycoformycin and Rituximab

By  

Acta Haematologica, Vol. 111, Iss. 4, 2004-05 ,pp. : 185-188

Karger

Access to resources Recommend Favorite

Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis—TAFRO syndrome

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1091-1092

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single‐centre study

By  

NEPHROLOGY, Vol. 21, Iss. 10, 2016-10 ,pp. : 887-892

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of acute myelogenous leukaemia in patients aged 50–65: idarubicin is more effective than zorubicin for remission induction and prolonged disease‐free survival can be obtained using a unique consolidation course

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 333-341

John Wiley & Sons Inc

Access to resources Recommend Favorite